CNIPA.AI

Company patentsCompare

HEAD TO HEAD

BeOne MedicinesCXMT

Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.

Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds

This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.

Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.

BeOne Medicines: Applicant names included in these statistics — BEIGENE LTD · BEIGENE SWITZERLAND GMBH · BEONE MEDICINES I GMBHReviewed names not covered — BEIGENE, LTD. · BEONE MEDICINES LTD. · 百济神州有限公司

CXMT: Applicant names included in these statistics — CHANGXIN MEMORY TECH INC · CHANGXIN MEMORY TECHNOLOGIES INC · CHANGXIN TECH GROUP CO LTD · CXMT CORPReviewed names not covered — CHANGXIN MEMORY TECHNOLOGIES, INC. · CXMT CORPORATION · 睿力集成电路有限公司 · 长鑫存储技术有限公司 · 长鑫科技集团股份有限公司

Publications
385
Invention share
55%
Concentration
1.24
Green technology
—
Publications
1,570
Invention share
98%
Concentration
0.58
Green technology
—
0.00Field similarity
Cosine similarity of application counts across 35 fields. 1 is identical, 0 is no overlap.

01Technology field mirror

The 12 fields with the largest combined share. Share shows structure; count shows scale.

Technology field mirror
BeOne MedicinesTechnology fieldCXMT
90.6%
Pharmaceuticals
0%
0%
Semiconductors
67.9%
53.8%
Organic fine chemistry
0%
36.6%
Biotechnology
0%
0.3%
Computer technology
33.6%
0%
Basic communication processes
5.3%
0%
Measurement
2.3%
0%
Optics
2.2%
0%
Control
1.4%
0%
Electrical machinery, apparatus, energy
1.2%
0.5%
Analysis of biological materials
0%
0.3%
Chemical engineering
0.3%

Inspect one technology field

Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.

CXMT

Collected applications
512
Share of collected applications with IPC
33.6%

Coverage is incomplete; counts and shares describe only the collected subset.

View CXMT publications in this field

One application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.

02Same problem: shared IPC subclasses

The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.

G01NAnalysing materials
BeOne Medicines2
CXMT3
G06TImage processing
BeOne Medicines1
CXMT4
B01DSeparation, filtering
BeOne Medicines1
CXMT1

03Where each one leans

Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.

BeOne Medicines

  • A61K
    BeOne Medicines
    323
    CXMT
    —
  • A61P
    BeOne Medicines
    274
    CXMT
    —
  • C07DHeterocyclic compounds
    BeOne Medicines
    195
    CXMT
    —
  • C07K
    BeOne Medicines
    131
    CXMT
    —
  • C12NMicroorganisms, enzymes
    BeOne Medicines
    20
    CXMT
    —
  • C07C
    BeOne Medicines
    8
    CXMT
    —

CXMT

  • H10BMemory devices
    BeOne Medicines
    —
    CXMT
    689
  • G11CStatic stores
    BeOne Medicines
    —
    CXMT
    480
  • H01LSemiconductor devices
    BeOne Medicines
    —
    CXMT
    378
  • H10D
    BeOne Medicines
    —
    CXMT
    220
  • H10W
    BeOne Medicines
    —
    CXMT
    161
  • H10P
    BeOne Medicines
    —
    CXMT
    68

04Publication rhythm

BeOne MedicinesCXMTPublications per period
Publications per period
PeriodBeOne MedicinesCXMT
2025-01≥28 (partial coverage)≥233 (partial coverage)
2025-02≥38 (partial coverage)≥180 (partial coverage)
2025-03≥43 (partial coverage)≥99 (partial coverage)
2025-04≥29 (partial coverage)≥79 (partial coverage)
2025-05≥40 (partial coverage)≥108 (partial coverage)
2025-06≥30 (partial coverage)≥177 (partial coverage)
2025-07≥21 (partial coverage)≥156 (partial coverage)
2025-08≥35 (partial coverage)≥112 (partial coverage)
2025-09≥23 (partial coverage)≥148 (partial coverage)
2025-10≥34 (partial coverage)≥89 (partial coverage)
2025-11≥42 (partial coverage)≥64 (partial coverage)
2025-12≥22 (partial coverage)≥125 (partial coverage)

Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.

Publication timing follows examination and publication cycles, not R&D intensity.

What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.

What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.

Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.